Nothing Special   »   [go: up one dir, main page]

OA12403A - Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament. - Google Patents

Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament. Download PDF

Info

Publication number
OA12403A
OA12403A OA1200300107A OA1200300107A OA12403A OA 12403 A OA12403 A OA 12403A OA 1200300107 A OA1200300107 A OA 1200300107A OA 1200300107 A OA1200300107 A OA 1200300107A OA 12403 A OA12403 A OA 12403A
Authority
OA
OAPI
Prior art keywords
tiotropium bromide
crystalline
monohydrate
crystalline monohydrate
bromide
Prior art date
Application number
OA1200300107A
Other languages
English (en)
French (fr)
Inventor
Rolf Banholzer
Peter Sieger
Christian Kulinna
Michael Trunk
Manfred Ludwig August Graulich
Peter Specht
Helmut Meissner
Andreas Mathes
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA12403(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of OA12403A publication Critical patent/OA12403A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA1200300107A 2000-10-12 2001-09-28 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament. OA12403A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10050621 2000-10-12

Publications (1)

Publication Number Publication Date
OA12403A true OA12403A (en) 2006-04-18

Family

ID=7659568

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300107A OA12403A (en) 2000-10-12 2001-09-28 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament.

Country Status (47)

Country Link
EP (2) EP1326862B1 (bg)
JP (1) JP3764422B2 (bg)
KR (1) KR100823860B1 (bg)
CN (2) CN100519558C (bg)
AP (1) AP1572A (bg)
AR (2) AR034389A1 (bg)
AT (1) ATE276253T1 (bg)
AU (2) AU2002214996B2 (bg)
BG (1) BG66161B1 (bg)
BR (1) BR0114584A (bg)
CA (1) CA2425539C (bg)
CR (1) CR6938A (bg)
CZ (1) CZ301841B6 (bg)
DE (1) DE50103666D1 (bg)
DK (1) DK1326862T3 (bg)
DZ (1) DZ3478A1 (bg)
EA (1) EA004381B1 (bg)
EC (1) ECSP034540A (bg)
EE (1) EE04567B1 (bg)
EG (1) EG24142A (bg)
ES (1) ES2228965T3 (bg)
GE (1) GEP20063905B (bg)
HK (2) HK1060567A1 (bg)
HR (1) HRP20030276B1 (bg)
HU (1) HU226830B1 (bg)
IL (2) IL155335A0 (bg)
IS (1) IS2339B (bg)
MA (1) MA25842A1 (bg)
ME (2) ME00243B (bg)
MX (1) MXPA03003221A (bg)
MY (1) MY126931A (bg)
NO (1) NO328465B1 (bg)
NZ (1) NZ525733A (bg)
OA (1) OA12403A (bg)
PE (1) PE20020422A1 (bg)
PL (1) PL207870B1 (bg)
PT (1) PT1326862E (bg)
RS (1) RS50218B (bg)
SA (1) SA01220412B1 (bg)
SI (1) SI1326862T1 (bg)
SK (1) SK287009B6 (bg)
TR (1) TR200402579T4 (bg)
TW (1) TW589313B (bg)
UA (1) UA74215C2 (bg)
UY (2) UY26962A1 (bg)
WO (1) WO2002030928A1 (bg)
ZA (1) ZA200302500B (bg)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1401445E (pt) * 2001-06-22 2006-10-31 Boehringer Ingelheim Pharma Anticolinergico cristalino, processo para a sua preparacao e sua utilizacao para a preparacao de um medicamento
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
UA82414C2 (uk) * 2003-11-03 2008-04-10 Бёрингер Ингельхайм Интернациональ Гмбх Солі тіотропію, спосіб їх одержання, а також лікарські композиції, які їх містять
BRPI0416136A (pt) * 2003-11-03 2007-01-02 Boehringer Ingelheim Int processo para a produção de sais de tiotrópio, sais de tiotrópio, bem como formulações de medicamentos contendo os mesmos
SI1682542T1 (sl) * 2003-11-03 2010-04-30 Boehringer Ingelheim Int Nov kristaliniŽŤen anhidrat z antiholinergiŽŤno uŽŤinkovitostjo
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
DK1781298T3 (da) 2004-04-22 2012-05-07 Boehringer Ingelheim Int Lægemiddelkombinationer indeholdende benzoxazin til behandling af luftvejs-sygdomme
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
UA95063C2 (ru) * 2004-10-21 2011-07-11 Бёрингер Ингельхайм Интернациональ Гмбх Блистерная упаковка для применения в ингаляторах
EP1858554A2 (en) * 2005-03-09 2007-11-28 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
EP1877376A1 (de) 2005-04-28 2008-01-16 Boehringer Ingelheim International GmbH Neue verbindungen zur behandlung von entzündlichen erkrankungen
BRPI0609295A2 (pt) 2005-05-02 2010-03-23 Boehringer Ingelheim Int formas cristalinas de brometo de tiotràpio, composiÇço farmacÊutica, uso e mÉtodo para preparar as mesmas
RU2007144531A (ru) * 2005-05-02 2009-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Новые кристаллические формы тиотропийбромида
WO2006134021A2 (en) * 2005-06-15 2006-12-21 Boehringer Ingelheim International Gmbh Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
BRPI0614394A2 (pt) * 2005-08-06 2011-03-29 Boehringer Ingelheim Int uso de sais de tiotrópio
DK1917253T3 (da) 2005-08-15 2015-03-30 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af betamimetika
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
MX2007009988A (es) 2005-12-19 2008-02-22 Sicor Inc Formas novedosas de bromuro de tiotropio y procesos para su preparacion.
EP1966196A2 (en) * 2005-12-19 2008-09-10 Sicor, Inc. Pure and stable tiotropium bromide
CN101355937A (zh) * 2006-01-04 2009-01-28 贝林格尔·英格海姆国际有限公司 噻托铵盐在治疗中度持续性哮喘中的用途
NZ563488A (en) 2006-04-19 2010-04-30 Boehringer Ingelheim Int Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP2051714B1 (de) 2006-08-07 2011-04-13 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
PE20080610A1 (es) 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
EA019480B1 (ru) 2007-10-19 2014-04-30 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные пиперидинодигидротиенопиримидины в качестве ингибиторов pde4
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2010011813A1 (en) * 2008-07-23 2010-01-28 Alkermes, Inc. Complex of trospium and pharmaceutical compositions thereof
CN103724328B (zh) 2008-12-19 2015-10-14 贝林格尔.英格海姆国际有限公司 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
CA2931876A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Anhydrate of tiotropium bromide
MX2012006964A (es) 2009-12-17 2012-07-17 Boehringer Ingelheim Int Nuevos antagonistas del receptor ccr2 y usos de los mismos.
JP5658272B2 (ja) 2009-12-17 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２の新規アンタゴニスト及びこれらの使用
NZ600857A (en) 2010-01-29 2014-06-27 Boehringer Ingelheim Int Substituted naphthyridines and their use as syk kinase inhibitors
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2569298B1 (en) 2010-05-12 2015-11-25 Boehringer Ingelheim International GmbH Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP5647339B2 (ja) 2010-05-17 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２アンタゴニスト及びこれらの使用
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
EP2576538B1 (en) 2010-06-01 2015-10-28 Boehringer Ingelheim International GmbH New CCR2 antagonists
EP2668177B1 (en) 2011-01-28 2014-10-22 Boehringer Ingelheim International GmbH Substituted pyridinyl-pyrimidines and their use as medicaments
TR201102068A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
EP2721025B1 (en) 2011-06-16 2015-11-25 Boehringer Ingelheim International Gmbh New selective ccr2 antagonists
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
EA024845B1 (ru) 2011-07-26 2016-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хинолины и их применение в качестве лекарственных средств
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
SI2914593T1 (sl) 2012-11-05 2017-05-31 Zentiva, K.S. Stabilizacija tiotropijevih solvatov
EP2913332A1 (en) * 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
EA032097B1 (ru) 2014-03-19 2019-04-30 Бёрингер Ингельхайм Интернациональ Гмбх Гетероарильные ингибиторы syk
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
RU2567539C1 (ru) * 2015-02-04 2015-11-10 Индивидуальный предприниматель Михайлов Олег Ростиславович КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
WO2018084817A2 (en) * 2016-11-04 2018-05-11 Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇ A new form of active agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB2288978B (en) * 1992-12-09 1997-04-09 Boehringer Ingelheim Pharma Hydrocarbon inhalant solutions stabilised by organic or inorganic acids
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
WO2000007567A1 (de) * 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen

Also Published As

Publication number Publication date
HRP20030276B1 (en) 2006-02-28
ES2228965T3 (es) 2005-04-16
DE50103666D1 (de) 2004-10-21
AU1499602A (en) 2002-04-22
SK4362003A3 (en) 2003-08-05
IS2339B (is) 2008-02-15
PE20020422A1 (es) 2002-06-28
HUP0301022A3 (en) 2005-12-28
SI1326862T1 (en) 2005-02-28
RS50218B (sr) 2009-07-15
IL155335A (en) 2009-02-11
MEP40008A (en) 2011-02-10
ATE276253T1 (de) 2004-10-15
EP1326862A1 (de) 2003-07-16
TR200402579T4 (tr) 2004-12-21
EG24142A (en) 2008-08-06
HRP20030276A2 (en) 2005-02-28
BG66161B1 (bg) 2011-09-30
JP2004526668A (ja) 2004-09-02
CA2425539C (en) 2007-04-03
SK287009B6 (sk) 2009-09-07
MA25842A1 (fr) 2003-07-01
PL366041A1 (en) 2005-01-24
AR034389A1 (es) 2004-02-25
YU27303A (sh) 2006-05-25
GEP20063905B (en) 2006-08-25
HU226830B1 (en) 2009-11-30
EP1468998A1 (de) 2004-10-20
AP1572A (en) 2006-02-13
DZ3478A1 (fr) 2002-04-18
UY34901A (es) 2015-02-27
EE04567B1 (et) 2005-12-15
CN1221549C (zh) 2005-10-05
EE200300171A (et) 2003-06-16
CN1733761A (zh) 2006-02-15
NO328465B1 (no) 2010-02-22
EP1326862B1 (de) 2004-09-15
NO20031694D0 (no) 2003-04-11
MY126931A (en) 2006-10-31
AU2002214996B2 (en) 2007-03-15
DK1326862T3 (da) 2004-11-22
TW589313B (en) 2004-06-01
CZ301841B6 (cs) 2010-07-07
NO20031694L (no) 2003-04-11
MXPA03003221A (es) 2004-12-03
JP3764422B2 (ja) 2006-04-05
IS6772A (is) 2003-04-09
BR0114584A (pt) 2003-08-26
EA200300457A1 (ru) 2003-10-30
PL207870B1 (pl) 2011-02-28
UY26962A1 (es) 2002-06-20
AR068527A2 (es) 2009-11-18
CA2425539A1 (en) 2003-04-11
IL155335A0 (en) 2003-11-23
CN1469877A (zh) 2004-01-21
WO2002030928A1 (de) 2002-04-18
PT1326862E (pt) 2004-11-30
BG107687A (bg) 2003-09-30
CN100519558C (zh) 2009-07-29
KR20030042008A (ko) 2003-05-27
CR6938A (es) 2004-10-28
HK1060567A1 (en) 2004-08-13
ECSP034540A (es) 2003-07-25
UA74215C2 (uk) 2005-11-15
SA01220412B1 (ar) 2006-11-05
ME00243B (me) 2011-05-10
KR100823860B1 (ko) 2008-04-21
HK1086557A1 (en) 2006-09-22
NZ525733A (en) 2005-01-28
EA004381B1 (ru) 2004-04-29
ZA200302500B (en) 2004-04-22
HUP0301022A2 (hu) 2003-10-28
AP2003002775A0 (en) 2003-03-31

Similar Documents

Publication Publication Date Title
OA12403A (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament.
US6777423B2 (en) Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
KR100971616B1 (ko) 결정질 항콜린제, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US20030087927A1 (en) Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
JPH08512315A (ja) オメプラゾールマグネシウム
JPH04266824A (ja) 医薬品
JP2018502888A (ja) エルゴリン化合物およびその使用
TW201420100A (zh) 作為白三烯ａ４水解酶的調節劑之噻唑并吡啶-２-基氧基-苯基及噻唑并吡□-２-基氧基-苯基胺類
JPH04217662A (ja) テトラヒドロベンズインドール誘導体の結晶性塩
AU2009322420A1 (en) Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
TW202313566A (zh) 製備氨磺必利之結晶型的方法
CN117377658A (zh) 喹啉衍生物化合物的制备方法
CZ20003343A3 (cs) Krystalická forma paroxetinu